This course offers an essential opportunity to enhance data integrity and compliance for cloud systems. It provides a practical model for documentation and change control, crucial for meeting ...
BioPharma Consulting Group today announced the launch of a new digital transformation advisory framework designed to ...
A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...
This training unlocks opportunities for companies to modernize GxP validation by shifting to Computer Software Assurance, ensuring data integrity and compliance with FDA regulations, and addressing ...
Embrace Computer Software Assurance (CSA) for modern life-sciences by focusing on meaningful evidence rather than burdensome documentation. This approach enhances efficiency, aligns with FDA ...
NDTV Profit on MSN
Cipla Shares Fall 4% After USFDA Flags Compliance Issues At Pharmathen's Rodopi Facility
The form includes nine observations highlighting serious concerns over current Good Manufacturing Practices (cGMP).
Telangana DCA’s 2025 annual action taken report highlights expansion of enforcement & global regulatory synergy: Peethaambaran Kunnathoor, Chennai Monday, January 12, 2026, 08:0 ...
cGxP Lifeline conference 2025 themed ‘Defining Ethics, Elevating Quality Standards’ hosted in Mumbai
In order to usher in domestic & global regulatory compliance in pharma sector under the current revised Schedule M regime in India, cGxP Lifeline hosted its first Annual Conference 2025 in Mumbai ...
This course offers a strategic edge by refining cloud system classification through CSA principles, preventing compliance pitfalls and inefficiencies. It empowers teams to enhance validation precision ...
2don MSNOpinion
I Tried to Be the Government. It Did Not Go Well.
“I can’t help but notice we are in a Whole Foods,” I tell a Whole Foods employee who—perhaps having noticed me walking around ...
Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...
Global Pharmaceutical Manufacturing Equipment Market OverviewThe global pharmaceutical manufacturing equipment market is on a growth trajectory, projected to expand at a CAGR of 6–8% over the forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback